IDHCL Stock Overview
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Integrated Diagnostics Holdings plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.36 |
| 52 Week High | US$0.63 |
| 52 Week Low | US$0.29 |
| Beta | 0.50 |
| 1 Month Change | -8.52% |
| 3 Month Change | -1.08% |
| 1 Year Change | -18.89% |
| 3 Year Change | -67.70% |
| 5 Year Change | -70.80% |
| Change since IPO | -58.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| IDHCL | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 1.1% | 1.4% | 2.7% |
| 1Y | -18.9% | -29.1% | 0.3% |
Return vs Industry: IDHCL exceeded the UK Healthcare industry which returned -29.5% over the past year.
Return vs Market: IDHCL underperformed the UK Market which returned -1.8% over the past year.
Price Volatility
| IDHCL volatility | |
|---|---|
| IDHCL Average Weekly Movement | 10.4% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: IDHCL has not had significant price volatility in the past 3 months.
Volatility Over Time: IDHCL's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 6,692 | Hend El Sherbini | www.idhcorp.com |
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, including positron emission tomography – computed tomography (PET-CT), magnetic resonance imaging (MRI), computed tomography (CT), mammography, ultrasound, x-ray, electromyography (EMG), electroencephalography, electroencephalogram (EEG), and electrocardiogram (ECG), as well as operates cath lab facilities.
Integrated Diagnostics Holdings plc Fundamentals Summary
| IDHCL fundamental statistics | |
|---|---|
| Market cap | US$210.00m |
| Earnings (TTM) | US$10.60m |
| Revenue (TTM) | US$85.62m |
19.8x
P/E Ratio2.5x
P/S RatioIs IDHCL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IDHCL income statement (TTM) | |
|---|---|
| Revenue | ج.م4.12b |
| Cost of Revenue | ج.م2.60b |
| Gross Profit | ج.م1.52b |
| Other Expenses | ج.م1.01b |
| Earnings | ج.م510.30m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.85 |
| Gross Margin | 36.98% |
| Net Profit Margin | 12.38% |
| Debt/Equity Ratio | 3.6% |
How did IDHCL perform over the long term?
See historical performance and comparison